1. Service Overview & International Regulatory Compliance Framework
Our global biopharmaceutical consultancy and engineering services deliver integrated, full-lifecycle technical and engineering solutions tailored for cross-border biomanufacturing development, fully compliant with FDA cGMP, EMA Annex 1, PIC/S harmonized GMP and ICH Q8/Q9/Q10 global quality risk management and data integrity standards. Covering regulatory consultancy, process optimization, facility design, sanitary engineering construction, system integration and CQV qualification, our one-stop service portfolio supports end-to-end industrialization for monoclonal antibodies, recombinant proteins, viral vectors and vaccines worldwide. Global biopharma projects commonly face systematic pain points including regional regulatory standard discrepancies, disjointed consulting and engineering execution, insufficient cross-border audit experience, mismatched process-facility layouts and incomplete global compliance dossiers. Combining international regulatory expertise and standardized engineering delivery capabilities, we unify cross-region quality and compliance benchmarks, delivering cost-effective, schedule-stabilized and fully audit-ready solutions for global biotech enterprises, multinational CMO operators and cross-border pharmaceutical industrial developers.
2. Core Service Philosophy & Global Integrated Advantages
Guided by risk-based global compliance governance and process-driven engineering determinism, our integrated consultancy and engineering model embeds international regulatory iteration rules and biomanufacturing intrinsic logic into every project stage. All process parameter optimization, facility zoning layout, sanitary fluid path design and utility system configuration are customized based on product critical quality attributes (CQAs) and critical process parameters (CPPs), realizing seamless linkage from regulatory consulting formulation to on-site engineering implementation. We strictly enforce ASME BPE sanitary specifications, ALCOA+ data integrity principles and cross-jurisdictional contamination control strategies throughout project delivery. Different from segmented service providers that separate consulting planning from engineering execution, our closed-loop service mechanism eliminates scheme-implementation deviations, avoids repeated project rectifications, shortens global facility readiness cycles and sustains long-term multi-region GMP inspection readiness for international biomanufacturing projects.
3. Four Core Global Service Modules & Standard Deliverables
Our complete global biopharmaceutical consultancy and engineering system consists of four interlocked full-process functional modules covering consultation, design, construction and compliance handover: global regulatory & process consultancy module, international standard engineering design module, GMP-compliant construction & integration module, and cross-border qualification & documentation module. The global consultancy module conducts multi-country regulatory gap analysis, process scale-up consulting, project feasibility assessment and compliance strategy formulation, providing market-adapted technical roadmaps for global project deployment. The engineering design module delivers BIM 3D optimized master planning, process sanitary layout, MEP & utility system design and P&ID schematic development, outputting URS and DQ documents compliant with global mainstream standards. The construction and integration module implements standardized sanitary installation, cleanroom classification construction, equipment system docking and multi-system linkage debugging with unified global execution specifications. The qualification and documentation module completes full IQ/OQ/PQ validation, process risk assessment and full-set English-version audit dossier sorting. Standard deliverables include global consulting reports, international engineering archives, validation packages and cross-market compliance supporting documents.
4. Global Application & Full Lifecycle Cross-Border Support
Our global consultancy and engineering services are widely applied in cross-border greenfield biomanufacturing campus construction, overseas brownfield GMP upgrading, international clinical pilot process platforms and multi-standard flexible global CMO facilities. All consulting schemes and engineering architectures adopt modular, scalable and future-proof design, reserving flexible expansion and process intensification interfaces to adapt to global regulatory updates and new biotherapeutic pipeline iteration. We provide full-lifecycle cross-border technical support including overseas project guidance, regulatory standard update consultation, on-site engineering supervision, post-handover operational optimization and multi-region pre-audit training. Through highly integrated global consulting and engineering capabilities, we help international clients eliminate cross-market compliance barriers, stabilize project quality and operational efficiency, and accelerate the global industrialization and commercialization of innovative biopharmaceutical products.
